Trial Management STREAM

  1. TMF Management In Clinical Trials 3/13/2023

    Elevate your knowledge of clinical trials and the Trial Master File by exploring three critical topics.

  2. Altasciences Has You Covered From Coast To Coast 1/30/2023

    With your success in mind, we designed an integrated early phase drug development offering with eight locations, to get you from lead candidate selection to clinical proof of concept, and beyond.

  3. Clinical Trials And TMF 101 Learning Series: 2nd Session 11/14/2022

    The “Clinical Trials and TMF 101 Learning Series” kicks off it’s second session with three industry experts, that goes through some of the basics of clinical trials.

  4. Learning About The Sensors In myMedidata 9/16/2025

    Learn how sensor data and advanced analytics can transform clinical research and enable your study to overcome data challenges, improving patient care.

  5. Perceptive eClinical 11/11/2024

    Learn about a randomization and trial supply management (RTSM) solution that helps keep your trial on track.

  6. Optimize Protocols For More Successful Trials 9/17/2024

    Find out how you can harness the power of AI and world-class data to recommend endpoints and inclusion/exclusion criteria for streamlined protocol design that results in more positive trial outcomes.

  7. What Is The Secret To Ongoing TMF Health? 8/22/2023

    Delve into specific tactics clinical teams can utilize for establishing immediate and long-lasting improvements to their TMF business processes.

  8. Why Disclosure As A Service? 6/3/2020

    Two clinical trial sponsors – one larger pharmaceutical company and one smaller biotech – share with TrialScope what their main reasons were for initially considering Disclosure as a Service. Watch the short video.

  9. Solving The Impossible In Glioblastoma With An AI Synthetic Control Arm 9/9/2022

    This video discusses Medicenna’s MDNA55-05 clinical trial; a single-arm, open-label, multicenter study that offers a promising opportunity to improve outcomes for recurrent glioblastoma.

  10. Digital Physical Activity Measures In Phase 3 Immunology Trials 2/25/2025

    Dr. Jie Shen, Research Fellow and Director of Digital Science at AbbVie, shares lessons learned from incorporating digital measures of physical activity into Phase 3 immunology clinical trials.